Source link : https://newshealth.biz/health-news/misleading-heart-drug-ad-jenavalve-deal-thwarted-sglt2-inhibitor-to-prevent-hf/
(MedPage Today) — A TV commercial for bempedoic acid/ezetimibe (Nexlizet) was deemed “false or misleading” by the FDA due to claims the drug is the only nonstatin to lower bad cholesterol and reduce the risk of heart attacks. After a 6-day court… Source link : https://www.medpagetoday.com/cardiology/generalcardiology/119399 Author : Publish date : 2026-01-13 19:48:00 Copyright for […]
The post ‘Misleading’ Heart Drug Ad; JenaValve Deal Thwarted; SGLT2 Inhibitor to Prevent HF first appeared on News Health.
—-
Author : News Health
Publish date : 2026-01-13 19:48:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8